LGL Group Inc (LGL)vsZepp Health Corp (ZEPP)
LGL
LGL Group Inc
$6.95
-1.70%
TECHNOLOGY · Cap: $47.42M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 6110% more annual revenue ($258.90M vs $4.17M). LGL leads profitability with a 16.5% profit margin vs -15.5%. LGL earns a higher WallStSmart Score of 53/100 (C-).
LGL
Buy53
out of 100
Grade: C-
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LGL.
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 50.8% YoY
Growing faster than its price suggests
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
ROE of 1.7% — below average capital efficiency
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : LGL
The strongest argument for LGL centers on Price/Book, EPS Growth, PEG Ratio. Profitability is solid with margins at 16.5% and operating margin at 9.8%. PEG of 0.84 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : LGL
The primary concerns for LGL are Market Cap, Return on Equity, P/E Ratio. A P/E of 65.9x leaves little room for execution misses.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
LGL profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LGL scores higher overall (53/100 vs 41/100), backed by strong 16.5% margins. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
LGL Group Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
LGL Group, Inc. is dedicated to the design, manufacture and marketing of frequency and spectrum control products in the United States and internationally. The company is headquartered in Orlando, Florida.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?